Insider · CIK 0001224110

FRIEL ROBERT F

Reports to the SEC for 7 companies · WASHINGTON, DC

sec.gov

Transactions

Companies

Filings

CIK

0001224110

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-14	XYLXylem Inc.A Award	Director	AAward	+2,481 sh	$116.88	+$290K	38,706
2026-05-04	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+791 sh	—	—	5,512.97
2025-05-13	XYLXylem Inc.A Award	Director	AAward	+1,851 sh	$126.93	+$235K	36,031
2025-05-06	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+1,071 sh	—	—	4,681.98
2024-05-16	XYLXylem Inc.A Award	Director	AAward	+1,647 sh	—	—	33,926
2024-04-23	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+564 sh	—	—	3,610.98
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−2,577 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−3,095 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−5,113 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−850 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−3,230 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−3,788 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−4,816 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−2,822 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−2,702 sh	—	—	0
2023-09-01	NUVASIVE INCRestricted Stock UnitD Disposition to Issuer	Director	DDisposition to Issuer	−2,130 sh	—	—	0
2023-06-09	NUVASIVE INCRSUsA Award	Director	AAward	+4,816 sh	—	—	4,816
2023-05-18	XYLXylem Inc.A Award	Director	AAward	+2,250 sh	—	—	32,017
2023-04-25	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+616 sh	—	—	3,046.98
2022-05-24	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+632 sh	—	—	2,430.98
2022-05-12	XYLXylem Inc.A Award	Director	AAward	+2,627 sh	—	—	29,538
2022-05-11	NUVASIVE INCRSUsA Award	Director	AAward	+3,788 sh	—	—	3,788
2021-05-18	NUVASIVE INCRSUsA Award	Director	AAward	+2,702 sh	—	—	2,702
2021-05-12	XYLXylem Inc.A Award	Director	AAward	+1,925 sh	—	—	26,735
2021-05-04	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+577 sh	—	—	1,798.98
2020-05-28	NUVASIVE INCRSUsA Award	Director	AAward	+3,095 sh	—	—	3,095
2020-05-13	XYLXylem Inc.A Award	Director	AAward	+3,737 sh	—	—	24,596
2020-05-05	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+975 sh	—	—	1,219.198
2020-02-18	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+244 sh	—	—	244
2019-05-15	XYLXylem Inc.A Award	Director	AAward	+1,831 sh	—	—	20,718
2019-05-09	NUVASIVE INCRSUsA Award	Director	AAward	+2,577 sh	—	—	2,577
2019-02-13	RVTYREVVITY, INC.F Tax Payment	Director, Chairman and CEO	FTax Payment	−16.9K sh	$91.83	−$1.55M	570,662
2019-02-05	RVTYREVVITY, INC. · NQ Stock Option (right to buy)A Award	Director, Chairman and CEO	AAward	+62.1K sh	—	—	62,059
2019-02-05	RVTYREVVITY, INC.A Award	Director, Chairman and CEO	AAward	+14.9K sh	—	—	587,551
2018-10-01	RVTYREVVITY, INC.S Sale	Director, Chairman and CEO	SSale	−104K sh	$96.75	−$10.1M	618,972
2018-10-01	RVTYREVVITY, INC.M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+151K sh	$33.87	+$5.1M	723,269
2018-10-01	RVTYREVVITY, INC. · NQ Stock Option (right to buy)M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−151K sh	—	—	0
2018-10-01	RVTYREVVITY, INC.S Sale	Director, Chairman and CEO	SSale	−46.3K sh	$97.73	−$4.53M	572,657
2018-08-02	RVTYREVVITY, INC.M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+216K sh	$26.14	+$5.64M	788,527
2018-08-02	RVTYREVVITY, INC. · NQ Stock Option (right to buy)M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−216K sh	—	—	0
2018-08-02	RVTYREVVITY, INC.S Sale	Director, Chairman and CEO	SSale	−216K sh	$81.62	−$17.6M	572,657
2018-08-01	RVTYREVVITY, INC.M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	+2,709 sh	$26.14	+$70.8K	575,366
2018-08-01	RVTYREVVITY, INC. · NQ Stock Option (right to buy)M Exercise/Conversion	Director, Chairman and CEO	MExercise/Conversion	−2,709 sh	—	—	215,870
2018-08-01	RVTYREVVITY, INC.S Sale	Director, Chairman and CEO	SSale	−2,709 sh	$80.00	−$217K	572,657
2018-05-09	XYLXylem Inc.A Award	Director	AAward	+1,947 sh	—	—	18,805
2018-05-03	NUVASIVE INCRSUsA Award	Director	AAward	+3,230 sh	—	—	3,230
2018-02-05	RVTYREVVITY, INC.F Tax Payment	Director, Chairman and CEO	FTax Payment	−16.4K sh	$78.08	−$1.28M	572,657
2018-01-30	RVTYREVVITY, INC. · NQ Stock Option (right to buy)A Award	Director, Chairman and CEO	AAward	+75.9K sh	—	—	75,947
2018-01-30	RVTYREVVITY, INC.A Award	Director, Chairman and CEO	AAward	+17.1K sh	—	—	589,031
2017-05-18	NUVASIVE INCRSUsA Award	Director	AAward	+2,130 sh	—	—	2,130

Recent filings

Accepted (ET)
May 154
FRIEL ROBERT F0001524472-26-000082
SEC(opens sec.gov)
May 64
FRIEL ROBERT F0000105770-26-000059
SEC(opens sec.gov)
May 144
FRIEL ROBERT F0001562180-25-003810
SEC(opens sec.gov)
May 84
FRIEL ROBERT F0001127602-25-013716
SEC(opens sec.gov)
May 204
FRIEL ROBERT F0001562180-24-004225
SEC(opens sec.gov)
Apr 254
FRIEL ROBERT F0001127602-24-013402
SEC(opens sec.gov)
Sep 54
FRIEL ROBERT F0001209191-23-048181
SEC(opens sec.gov)
Jun 124
FRIEL ROBERT F0001209191-23-036447
SEC(opens sec.gov)
May 224
FRIEL ROBERT F0001562180-23-004394
SEC(opens sec.gov)
Apr 274
FRIEL ROBERT F0001562180-23-003698
SEC(opens sec.gov)
May 264
FRIEL ROBERT F0001562180-22-004433
SEC(opens sec.gov)

Companies

Address

C/O XYLEM INC. 301 WATER STREET SE

WASHINGTON, DC, 20003